The revenue from antiretroviral drug formulations of Aurobindo Pharma Limited in fiscal year 2020 was over 12 billion Indian rupees. This value was an increase of over nine percent from the previous financial year 2019.
Revenue from antiretroviral drug formulations by Aurobindo Pharma Limited from financial year 2013 to 2020 (in billion Indian rupees)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Single Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access
Corporate solution including all features.
* Prices do not include sales tax.
Further Content: You might find this interesting as well
Statistics
- Aurobindo Pharma's revenue from growth market formulations FY 2013-2020
- Aurobindo Pharma's expenditure on R&D FY 2017-2020, by type
- Aurobindo Pharma's revenue from U.S. formulations FY 2013-2020
- Aurobindo Pharma's EBITDA FY 2013-2020
- Aurobindo Pharma's revenue share 2020 by market
- Aurobindo Pharma's net debt to EBITDA ratio FY 2013-2020
- Aurobindo Pharma's net debt to equity ratio FY 2013-2020
- Aurobindo Pharma's EBITDA margin FY 2013-2020
- Aurobindo Pharma's ANDA filings 2019 by therapy
- Dr. Reddy's Laboratories' net worth FY 2014-2020
- Dr. Reddy's Laboratories' return on capital employed FY 2013-2020
- Dr. Reddy's Laboratories' revenue FY 2017-2020 by product segment
- Dr. Reddy's Laboratories' revenue FY 2014-2020
- Dr. Reddy's Laboratories' EBITDA FY 2014-2020
Aurobindo Pharma. (August 4, 2020). Revenue from antiretroviral drug formulations by Aurobindo Pharma Limited from financial year 2013 to 2020 (in billion Indian rupees) [Graph]. In Statista. Retrieved February 24, 2021, from https://www.statista.com/statistics/996262/india-aurobindo-pharma-arv-formulations-revenue/
Aurobindo Pharma. "Revenue from antiretroviral drug formulations by Aurobindo Pharma Limited from financial year 2013 to 2020 (in billion Indian rupees)." Chart. August 4, 2020. Statista. Accessed February 24, 2021. https://www.statista.com/statistics/996262/india-aurobindo-pharma-arv-formulations-revenue/
Aurobindo Pharma. (2020). Revenue from antiretroviral drug formulations by Aurobindo Pharma Limited from financial year 2013 to 2020 (in billion Indian rupees). Statista. Statista Inc.. Accessed: February 24, 2021. https://www.statista.com/statistics/996262/india-aurobindo-pharma-arv-formulations-revenue/
Aurobindo Pharma. "Revenue from Antiretroviral Drug Formulations by Aurobindo Pharma Limited from Financial Year 2013 to 2020 (in Billion Indian Rupees)." Statista, Statista Inc., 4 Aug 2020, https://www.statista.com/statistics/996262/india-aurobindo-pharma-arv-formulations-revenue/
Aurobindo Pharma, Revenue from antiretroviral drug formulations by Aurobindo Pharma Limited from financial year 2013 to 2020 (in billion Indian rupees) Statista, https://www.statista.com/statistics/996262/india-aurobindo-pharma-arv-formulations-revenue/ (last visited February 24, 2021)